Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 33
Filtrer
Plus de filtres










Gamme d'année
1.
PLoS Negl Trop Dis ; 18(7): e0012302, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38950061

RÉSUMÉ

BACKGROUND: Giardiasis and zinc deficiency have been identified as serious health problems worldwide. Although Zn depletion is known to occur in giardiasis, no work has investigated whether changes occur in brain structures. METHODS: Three groups of gerbils were used: control (1), orogastrically inoculated on day 3 after birth with trophozoites of two isolates of Giardia intestinalis (HGINV/WB) group (2 and 3). Estimates were made at five ages covering: establishment of infection, Giardia population growth, natural parasite clearance and a post-infection age. QuantiChrome zinc assay kit, cresyl violet staining and TUNEL technique were used. RESULTS: A significant decrease (p<0.01) in tissue zinc was observed and persisted after infection. Cytoarchitectural changes were observed in 75% of gerbils in the HGINV or WB groups. Ectopic pyramidal neurons were found in the cornus ammonis (CA1-CA3). At 60 and 90 days of age loss of lamination was clearly visible in CA1. In the dentate gyrus (DG), thinning of the dorsal lamina and abnormal thickening of the ventral lamina were observed from 30 days of age. In the cerebellum, we found an increase (p<0.01) in the thickness of the external granular layer (EGL) at 14 days of age that persisted until day 21 (C 3 ± 0.3 µm; HGINV 37 ± 5 µm; WB 28 ± 3 µm); Purkinje cell population estimation showed a significant decrease; a large number of apoptotic somas were observed scattered in the molecular layer; in 60 and 90 days old gerbils we found granular cell heterotopia and Purkinje cell ectopia. The pattern of apoptosis was different in the cerebellum and hippocampus of parasitized gerbils. CONCLUSION: The morphological changes found suggest that neuronal migration is affected by zinc depletion caused by giardiasis in early postnatal life; for the first time, the link between giardiasis-zinc depletion and damaged brain structures is shown. This damage may explain the psychomotor/cognitive delay associated with giardiasis. These findings are alarming. Alterations in zinc metabolism and signalling are known to be involved in many brain disorders, including autism.


Sujet(s)
Cervelet , Gerbillinae , Giardia lamblia , Giardiase , Hippocampe , Zinc , Animaux , Gerbillinae/parasitologie , Zinc/déficit , Zinc/métabolisme , Giardiase/parasitologie , Giardiase/anatomopathologie , Cervelet/anatomopathologie , Cervelet/parasitologie , Hippocampe/anatomopathologie , Hippocampe/parasitologie , Giardia lamblia/croissance et développement , Mâle , Modèles animaux de maladie humaine
2.
Int J Mol Sci ; 25(11)2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38892427

RÉSUMÉ

Neurotoxicity is a major obstacle in the effectiveness of Cisplatin in cancer chemotherapy. In this process, oxidative stress and inflammation are considered to be the main mechanisms involved in brain and lung toxicity. The aim of the present work was to study the influence of the amount of protein on some oxidative parameters in the brain and lungs of rats treated with Cisplatin (CP) and N-Acetylcysteine (NAC) as neuroprotectors. Four groups of Wistar rats, each containing six animals, were fed with a protein diet at 7% for 15 days. Thereafter, the groups were given either a unique dose of CP® 5 mg/kg or NAC® 5 mg/kg as follows: group 1 (control), NaCl 0.9% vehicle; group 2, CP; group 3, NAC; and group 4, NAC + CP. The animals were sacrificed immediately after the treatments. Blood samples were collected upon sacrifice and used to measure blood triglycerides and glucose. The brain and lungs of each animal were obtained and used to assay lipid peroxidation (TBARS), glutathione (GSH), serotonin metabolite (5-HIAA), catalase, and the activity of Ca+2, and Mg+2 ATPase using validated methods. TBARS, H2O2, and GSH were found to be significantly decreased in the cortex and cerebellum/medulla oblongata of the groups treated with CP and NAC. The total ATPase showed a significant increase in the lung and cerebellum/medulla oblongata, while 5-HIAA showed the same tendency in the cortex of the same group of animals. The increase in 5-HIAA and ATPase during NAC and CP administration resulted in brain protection. This effect could be even more powerful when membrane fluidity is increased, thus proving the efficacy of combined NAC and CP drug therapy, which appears to be a promising strategy for future chemotherapy in malnourished patients.


Sujet(s)
Acétylcystéine , Cisplatine , Poumon , Rat Wistar , Animaux , Cisplatine/effets indésirables , Cisplatine/toxicité , Acétylcystéine/pharmacologie , Rats , Poumon/effets des médicaments et des substances chimiques , Poumon/métabolisme , Poumon/anatomopathologie , Peroxydation lipidique/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Mâle , Cerveau/effets des médicaments et des substances chimiques , Cerveau/métabolisme , Glutathion/métabolisme , Neuroprotecteurs/pharmacologie , Antinéoplasiques/effets indésirables
3.
Chem Biol Interact ; 398: 111086, 2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-38825054

RÉSUMÉ

Oleic acid (OA) is a monounsaturated compound with many health-benefitting properties such as obesity prevention, increased insulin sensitivity, antihypertensive and immune-boosting properties, etc. The aim of this study was to analyze the effect of oleic acid (OA) and some anticancer drugs against oxidative damage induced by nitropropionic acid (NPA) in rat brain. Six groups of Wistar rats were treated as follows: Group 1, (control); group 2, OA; group 3, NPA + OA; group 4, cyclophosphamide (CPP) + OA; group 5, daunorubicin (DRB) + OA; and group 6, dexrazoxane (DXZ) + OA. All compounds were administered intraperitoneally route, every 24 h for 5 days. Their brains were extracted to measure lipoperoxidation (TBARS), H2O2, Ca+2, Mg+2 ATPase activity, glutathione (GSH) and dopamine. Glucose, hemoglobin and triglycerides were measured in blood. In cortex GSH increased in all groups, except in group 2, the group 4 showed the highest increase of this biomarker. TBARS decrease, and dopamine increase in all regions of groups 4, 5 and 6. H2O2 increased only in cerebellum/medulla oblongata of group 5 and 6. ATPase expression decreased in striatum of group 4. Glucose increased in group 6, and hemoglobin increased in groups 4 and 5. These results suggest that the increase of dopamine and the antioxidant effect of oleic acid administration during treatment with oncologic agents could result in less brain injury.


Sujet(s)
Antinéoplasiques , Encéphale , Glutathion , Acide oléique , Stress oxydatif , Rat Wistar , Animaux , Stress oxydatif/effets des médicaments et des substances chimiques , Acide oléique/pharmacologie , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Rats , Mâle , Glutathion/métabolisme , Antinéoplasiques/pharmacologie , Peroxyde d'hydrogène/métabolisme , Composés nitrés/pharmacologie , Dopamine/métabolisme , Propionates/pharmacologie , Cyclophosphamide , Peroxydation lipidique/effets des médicaments et des substances chimiques , Daunorubicine/pharmacologie , Substances réactives à l'acide thiobarbiturique/métabolisme , Adenosine triphosphatases/métabolisme , Antioxydants/pharmacologie
4.
Children (Basel) ; 10(11)2023 Nov 01.
Article de Anglais | MEDLINE | ID: mdl-38002866

RÉSUMÉ

Epilepsy is a chronic neurological disease characterized by the presence of spontaneous seizures, with a higher incidence in the pediatric population. Anti-seizure medication (ASM) may produce adverse drug reactions (ADRs) with an elevated frequency and a high severity. Thus, the objective of the present study was to analyze, through intensive pharmacovigilance over 112 months, the ADRs produced by valproic acid (VPA), oxcarbazepine (OXC), phenytoin (PHT), and levetiracetam (LEV), among others, administered to monotherapy or polytherapy for Mexican hospitalized pediatric epilepsy patients. A total of 1034 patients were interviewed; 315 met the inclusion criteria, 211 patients presented ADRs, and 104 did not. A total of 548 ASM-ADRs were identified, and VPA, LEV, and PHT were the main culprit drugs. The most frequent ADRs were drowsiness, irritability, and thrombocytopenia, and the main systems affected were hematologic, nervous, and dermatologic. LEV and OXC caused more nonsevere ADRs, and PHT caused more severe ADRs. The risk analysis showed an association between belonging to the younger groups and polytherapy with ADR presence and between polytherapy and malnutrition with severe ADRs. In addition, most of the severe ADRs were preventable, and most of the nonsevere ADRs were nonpreventable.

5.
Int J Neurosci ; 132(6): 574-581, 2022 Jun.
Article de Anglais | MEDLINE | ID: mdl-32976735

RÉSUMÉ

AIM: The purpose was to measure the effect of Oseltamivir on oxidative biomarkers and dopaminergic and serotonergic systems in brain of rats with induced hypotriglyceridemia by Bezafibrate.Male young Wistar rats were treated as follows: group 1, NaCl 0.9%, (Controls); group 2, Oseltamivir (100 mg/kg); group 3, single dose of Bezafibrate (150 mg/kg); group 4, four dose of Bezafibrate; group 5, single dose of Bezafibrate + Oseltamivir and group 6, four doses of Bezafibrate + Oseltamivir. Drugs were given orally. Triglycerides, Dopamine, 5-hydroxyindoleacetic acid (5-HIAA), Glutathione (GSH), Hydrogen peroxide (H2O2), lipid peroxidation, as well as total ATPase activity were measured using validated methods. RESULTS: Oseltamivir treated animals showed lower GSH and lipid peroxidation levels and an increment in 5-HIAA in the three evaluated brain regions. Treatment with Oseltamivir also reduces H2O2 in the cortex and cerebellum/medulla oblongata. ATPase enzyme increased in these regions in the groups that were administered with Bezafibrate in repeated doses and in combination with Oseltamivir in single dose. Dopamine concentrations decreased in groups treated with Oseltamivir in the three evaluated regions. Also, there was a decrease in dopamine concentrations in the cerebellum/medulla oblongata of the animals treated with the combination of Oseltamivir and Bezafibrate.Innovation and conclusion: Animals with bezafibrate induced hypo-triglyceridemia that received Oseltamivir, either in single or repeated doses, have a higher improvement of their antioxidant activity and also experienced changes in the dopaminergic and serotonergic system in their brain, intending establish the beneficial of joint administration of both drugs in obese patients.


Sujet(s)
Dopamine , Oséltamivir , Adenosine triphosphatases/métabolisme , Animaux , Bézafibrate/pharmacologie , Encéphale/métabolisme , Glutathion/métabolisme , Peroxyde d'hydrogène/pharmacologie , Acide 5-hydroxy-indole-3-acétique/pharmacologie , Peroxydation lipidique , Mâle , Oséltamivir/pharmacologie , Stress oxydatif , Rats , Rat Wistar
6.
Diabetes Metab Syndr Obes ; 13: 3481-3486, 2020.
Article de Anglais | MEDLINE | ID: mdl-33061508

RÉSUMÉ

Several risks for diseases, such as atherosclerosis, renal diseases, and diabetes, have inextricably been linked with obesity. Nowadays, this health-risk-laden disease is being managed with assorted types of drugs, some of which guarantee modest benefits. The chronic inflammatory effect of obesity has a negative effect in insulin signaling, a situation attributable to insulin resistance that culminates in high blood sugar inputs seen in diseases such as type 2 diabetes and metabolic syndrome. Food such as beans with different bioactive compounds could reduce the risk of diabetic complications. Demand for bean products is growing because of its robust contents of several health-promoting components, eg, saponins. Saponins are characterized by containing lower glucose and cholesterol levels and have been doted with antioxidant activities, as well as anti-inflammatory and anti-diabetic effects. In this writing, the attributes of saponins in providing substantial health and nutritional benefits in humans, as well as in improving and ameliorating diabetic complications, were reviewed.

7.
Arch Physiol Biochem ; 126(1): 1-6, 2020 Feb.
Article de Anglais | MEDLINE | ID: mdl-30269600

RÉSUMÉ

Aim: This study tested the hypothesis that folic acid (FA) modulates biogenic amines and protects the brain against oxidative stress induced by 3-nitropropionic acid (3NPA).Methods: Male Wistar rats received (groups of six) for 5 d: FA (50 mg/kg); 3NPA (10 mg/kg); or FA +3NPA. At last day, rats were sacrificed, and their brain was obtained to measure the levels of dopamine, 5-hydroxiindol acetic acid (5-HIAA). Reduced glutathione (GSH), total ATPase, H2O2 and lipid peroxidation were measured.Results: GSH increased significantly in cortex of rats treated with FA. ATPase increased significantly in cerebellum/medulla oblongata and decreased in cortex of animal treated with 3NPA. 5-HIAA increased in striatum of rats that received 3NPA alone or combined with FA.Conclusion: 3NPA generates free radicals such effect can be counteracted with FA administration since this folate increases antioxidant capacity and modulates biogenic amines.


Sujet(s)
Antioxydants/pharmacologie , Cervelet/effets des médicaments et des substances chimiques , Cortex cérébral/effets des médicaments et des substances chimiques , Acide folique/pharmacologie , Neuroprotecteurs/pharmacologie , Composés nitrés/antagonistes et inhibiteurs , Propionates/antagonistes et inhibiteurs , Adenosine triphosphatases/métabolisme , Animaux , Cervelet/métabolisme , Cortex cérébral/métabolisme , Corps strié/effets des médicaments et des substances chimiques , Corps strié/métabolisme , Dopamine/métabolisme , Glutathion/agonistes , Glutathion/métabolisme , Peroxyde d'hydrogène/antagonistes et inhibiteurs , Peroxyde d'hydrogène/métabolisme , Acide 5-hydroxy-indole-3-acétique/agonistes , Acide 5-hydroxy-indole-3-acétique/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Mâle , Moelle allongée/effets des médicaments et des substances chimiques , Moelle allongée/métabolisme , Composés nitrés/administration et posologie , Stress oxydatif/effets des médicaments et des substances chimiques , Propionates/administration et posologie , Rats , Rat Wistar
8.
Nutr Cancer ; 71(1): 13-20, 2019.
Article de Anglais | MEDLINE | ID: mdl-30663392

RÉSUMÉ

During the early life, the diet of infants is mainly dominated by milk. Milk is a natural food rich in trace elements focus on essential elements. These elements are very necessary for human metabolism and since they cannot be synthesized by the body, the only source available for the humans to obtain them is by ingestion of natural food. This mini-review aims at updating the knowledge on trace elements, outlining their natural food sources, and their possible implications in common clinical disorders in early and adult life. However, it was found that consumption of food with micronutrients and trace elements may release intracellular compounds and offer oxidative protection or exacerbate oxidative damage to metabolically compromised cells.


Sujet(s)
Stress oxydatif , Oligoéléments/métabolisme , Animaux , Cuivre/métabolisme , Humains , Fer/métabolisme , Micronutriments/administration et posologie , Oligoéléments/administration et posologie , Oligoéléments/pharmacologie , Zinc/métabolisme
9.
Nutr Hosp ; 35(1): 194-200, 2018 Feb 13.
Article de Anglais | MEDLINE | ID: mdl-29565169

RÉSUMÉ

OBJECTIVE: The aim of this study was to evaluate the effect of splenda and stevia on dopamine and 5-HIAA levels, and some biomarkers of oxidative stress in the presence of cytarabine. METHODS: Forty-eight young male Wistar rats each with a weight of 80 g (four weeks of age), distributed in six groups of eight animals each, were treated as follows: group 1, control (NaCl 0.9% vehicle); group 2, cytarabine (0.6 g/kg); group 3, stevia (0.6 g/kg); group 4, cytarabine + stevia; group 5, splenda; and group 6, cytarabine + splenda. Cytarabine was given intravenously (IV) while stevia and splenda were administered orally for five days, using orogastric tube. At the end of treatment, the animals were sacrificed and glucose levels in blood were measured. The brains were dissected for histological analysis and homogenated to measure levels of dopamine, lipid peroxidation (TBARS), serotonin metabolite (5-HIAA), Na+, K+ ATPase activity, and glutathione (GSH), using validated methods. RESULTS: Sweeteners increased the glucose in animals that received cytarabine. Dopamine increased in cortex and decreased in striatum of animals that received stevia alone and combined with cytarabine. 5-HIAA decreased in striatum and cerebellum/medulla oblongata of animals that received sweeteners and cytarabine alone or combined. GSH increased in animals that received sweeteners and decreased with cytarabine. Lipoperoxidation decreased in groups that received sweeteners and cytarabine. Histopathological changes revealed marked degeneration of neuronal cells in animals treated with cytarabine. CONCLUSION: These results show that sweeteners as stevia or splenda may lead to the onset of unfavorable changes in dopamine and 5-HIAA. Antioxidant effects may be involved. Besides, histological changes revealed marked lesions of neuronal cells in experimental animals treated with cytarabine.


Sujet(s)
Antimétabolites antinéoplasiques/pharmacologie , Chimie du cerveau/effets des médicaments et des substances chimiques , Encéphale/anatomie et histologie , Encéphale/effets des médicaments et des substances chimiques , Cytarabine/pharmacologie , Édulcorants/pharmacologie , Animaux , Dopamine/métabolisme , Acide 5-hydroxy-indole-3-acétique/métabolisme , Mâle , Stress oxydatif/effets des médicaments et des substances chimiques , Rats , Rat Wistar , Stevia , Saccharose/analogues et dérivés
10.
Nutr. hosp ; 35(1): 194-200, ene.-feb. 2018. graf, ilus
Article de Anglais | IBECS | ID: ibc-172108

RÉSUMÉ

Objective: The aim of this study was to evaluate the effect of splenda and stevia on dopamine and 5-HIAA levels, and some biomarkers of oxidative stress in the presence of cytarabine. Methods: Forty-eight young male Wistar rats each with a weight of 80 g (four weeks of age), distributed in six groups of eight animals each, were treated as follows: group 1, control (NaCl 0.9% vehicle); group 2, cytarabine (0.6 g/kg); group 3, stevia (0.6 g/kg); group 4, cytarabine + stevia; group 5, splenda; and group 6, cytarabine + splenda. Cytarabine was given intravenously (IV) while stevia and splenda were administered orally for five days, using orogastric tube. At the end of treatment, the animals were sacrificed and glucose levels in blood were measured. The brains were dissected for histological analysis and homogenated to measure levels of dopamine, lipid peroxidation (TBARS), serotonin metabolite (5-HIAA), Na+, K+ ATPase activity, and glutathione (GSH), using validated methods. Results: Sweeteners increased the glucose in animals that received cytarabine. Dopamine increased in cortex and decreased in striatum of animals that received stevia alone and combined with cytarabine. 5-HIAA decreased in striatum and cerebellum/medulla oblongata of animals that received sweeteners and cytarabine alone or combined. GSH increased in animals that received sweeteners and decreased with cytarabine. Lipoperoxidation decreased in groups that received sweeteners and cytarabine. Histopathological changes revealed marked degeneration of neuronal cells in animals treated with cytarabine. Conclusion: These results show that sweeteners as stevia or splenda may lead to the onset of unfavorable changes in dopamine and 5-HIAA. Antioxidant effects may be involved. Besides, histological changes revealed marked lesions of neuronal cells in experimental animals treated with cytarabine (AU)


Objetivo: el objetivo fue evaluar el efecto de edulcorantes (splenda y stevia) sobre los niveles de dopamina, acido 5-hidroxiindolacetico (HIAA) y algunos biomarcadores de estrés oxidativo en presencia de citarabina. Métodos: cuarenta y ocho ratas Wistar machos con un peso aproximado de 80 g (cuatro semanas de edad), distribuidas en seis grupos de ocho animales cada uno, fueron tratados como sigue: grupo 1, control (NaCl 0,9% vehículo); grupo 2, citarabina (0,6 g/kg); grupo 3, stevia (0,6 g/kg); grupo 4, citarabina + stevia; grupo 5, splenda; y el grupo 6, citarabina + splenda. La citarabina fue administrada por vía intravenosa y la stevia y la splenda, por vía oral durante cinco días, utilizando una sonda orogastrica. Al final del tratamiento, los animales fueron sacrificados y se midieron los niveles de glucosa en sangre. Los cerebros fueron disecados para su análisis histológico y homogenizados para medir los niveles de dopamina, peroxidacion lipidica (TBARS), metabolito de la serotonina (5-HIAA), actividad de la Na+, K+ ATPasa y glutatión (GSH), usando métodos validados. Resultados: los edulcorantes aumentaron la glucosa en los animales que recibieron citarabina. La dopamina aumento en la corteza y disminuyo en el estriado de los animales que recibieron stevia sola y combinada con citarabina. La 5-HIAA disminuyo en el estriado y el cerebelo/ medula oblongata de animales que recibieron edulcorantes y citarabina sola o combinada. El GSH se incrementó en los animales que recibieron edulcorantes. La lipoperoxidacion disminuyo en los grupos que recibieron edulcorantes y citarabina. Estudios histopatológicos revelaron una degeneración neuronal importante en animales tratados con citarabina. Conclusión: los resultados muestran que los edulcorantes como stevia o splenda pueden conducir a la aparición de cambios desfavorables en los niveles de dopamina y 5-HIAA. Los cambios histológicos revelaron, además, lesiones marcadas de células neuronales en animales tratados con citarabina (AU)


Sujet(s)
Animaux , Rats , Cerveau , Cytarabine/pharmacocinétique , Édulcorants/pharmacocinétique , Interactions médicamenteuses , Modèles animaux de maladie humaine , Dopamine , Récepteurs dopaminergiques , Peroxydation lipidique , Glycémie , Stress oxydatif , Neurones
11.
Acta Pharm ; 66(3): 443-8, 2016 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-27383892

RÉSUMÉ

The study tested the hypothesis that cerebrolysin protects the brain from free radicals in rats treated with 3-nitropropionic acid (3-NPA). To address this hypothesis, the levels of dopamine (DA) and some oxidative stress biomarkers were measured after administration of 3-NPA. Young male Fischer rats were treated for three days with cerebrolysin, 3-NPA or both substances. Their brains were extracted, and DA, lipid peroxidation (LP), glutathione (GSH), calcium, and H2O2 were measured using validated methods. In the cortex, hemispheres and cerebellum/medulla oblongata of the group treated with cerebrolysin and 3-NPA, the levels of DA and LP decreased. In addition, calcium and H2O2 levels decreased in the hemispheres of the same group, while GSH increased in cortex. The increased dopamine metabolism due to the administration of cerebrolysin led to increased formation of radical species and oxidative stress, especially when free radicals were generated by 3-NPA.


Sujet(s)
Acides aminés/usage thérapeutique , Antioxydants/usage thérapeutique , Neurones dopaminergiques/effets des médicaments et des substances chimiques , Maladies neurodégénératives/prévention et contrôle , Neuroprotecteurs/usage thérapeutique , Syndromes neurotoxiques/prévention et contrôle , Stress oxydatif/effets des médicaments et des substances chimiques , Acides aminés/effets indésirables , Animaux , Antioxydants/effets indésirables , Calcium/métabolisme , Cortex cérébelleux/effets des médicaments et des substances chimiques , Cortex cérébelleux/métabolisme , Cervelet/effets des médicaments et des substances chimiques , Cervelet/métabolisme , Cerveau/effets des médicaments et des substances chimiques , Cerveau/métabolisme , Convulsivants/effets indésirables , Dopamine/métabolisme , Neurones dopaminergiques/métabolisme , Glutathion/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Mâle , Moelle allongée/effets des médicaments et des substances chimiques , Moelle allongée/métabolisme , Maladies neurodégénératives/induit chimiquement , Maladies neurodégénératives/métabolisme , Neuroprotecteurs/effets indésirables , Syndromes neurotoxiques/métabolisme , Composés nitrés/effets indésirables , Propionates/effets indésirables , Rats de lignée F344
12.
Saudi Pharm J ; 24(2): 213-9, 2016 Mar.
Article de Anglais | MEDLINE | ID: mdl-27013914

RÉSUMÉ

BACKGROUND: The knowledge about the pattern of prescription and consumption of solid oral drugs dispensed as unitary doses (UD) in Mexico is sparing. PURPOSE: The aim of this study was to describe the pattern of prescription and consumption of solid oral drugs dispensed as unitary doses (UD) in a third level private hospital of Mexico. A retrospective study of a 60-month period (from 2007 to 2011) was carried out to know the pattern of drugs dispensed as UD in a third level hospital. RESULTS: Among the principal drugs consumed were analgesic, antihypertensive, antibiotic, anti-inflammatory, antiepileptic, and diuretics. The dispensation of drugs per year was as follows: 181 drugs with 85,167 UD in 2007; 199 with 90,519 UD in 2008; 193 with 101,479 UD in 2009; 195 with 100,798 UD in 2010; and 198 with 103,913 UD in 2011. CONCLUSION: The findings confirmed that prescription and consumption of unitary doses in the hospitalization service increased, and revealed the extensive use of analgesics as the principal prescribed drug in this kind of hospital.

13.
Biomed Pharmacother ; 78: 210-215, 2016 Mar.
Article de Anglais | MEDLINE | ID: mdl-26898444

RÉSUMÉ

UNLABELLED: The aim of this work was to compare the effects of catechin (CAT), epicatechin (EPI) and N-ω-l-nitroarginine (L-NARG) on different endpoints of oxidative stress induced by quinolinic acid (QUIN) in a simple tissue preparation, rat striatal slices - with particular emphasis in the glutathione system - in order to provide revealing information on the antioxidant efficacy of these agents in an excitotoxic model. METHODS: Rat striatal slices were incubated for 1h in the presence of 100 µM QUIN and/or 85 µM CAT or EPI, or 100 µM L-NARG. Lipid peroxidation (LP) and the levels of reduced and oxidized glutathione (GSH and GSSG) were determined. RESULTS: The three agents tested completely blocked the QUIN-induced lipid peroxidation and recovered the QUIN-induced altered GSH/GSSG balance. No statistical differences were detected among the protective effects exerted by these antioxidants, suggesting similar efficacy and common antioxidant mechanisms. The antioxidant properties exhibited by these molecules on the excitotoxic model tested herein support an active role of glutathione and prompt their use as therapeutic tools in models of neurodegenerative disorders.


Sujet(s)
Catéchine/pharmacologie , Corps strié/anatomopathologie , Nitroarginine/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Acide quinolinique/toxicité , Animaux , Disulfure de glutathion/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Lipides/composition chimique , Mâle , Rat Wistar
14.
Oxid Med Cell Longev ; 2016: 9730467, 2016.
Article de Anglais | MEDLINE | ID: mdl-26770661

RÉSUMÉ

Dopamine is a neurotransmitter that is produced in the substantia nigra, ventral tegmental area, and hypothalamus of the brain. Dysfunction of the dopamine system has been implicated in different nervous system diseases. The level of dopamine transmission increases in response to any type of reward and by a large number of strongly additive drugs. The role of dopamine dysfunction as a consequence of oxidative stress is involved in health and disease. Introduce new potential targets for the development of therapeutic interventions based on antioxidant compounds. The present review focuses on the therapeutic potential of antioxidant compounds as a coadjuvant treatment to conventional neurological disorders is discussed.


Sujet(s)
Dopamine/métabolisme , Stress oxydatif , Animaux , Antidépresseurs/pharmacologie , Dopamine/composition chimique , Système endocrine/effets des médicaments et des substances chimiques , Système endocrine/métabolisme , Humains , Neuroprotecteurs/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Récepteurs dopaminergiques/métabolisme
15.
Pediatr Cardiol ; 36(5): 1019-23, 2015 Jun.
Article de Anglais | MEDLINE | ID: mdl-25612785

RÉSUMÉ

Pulmonary arterial hypertension (PAH) is a sickness with high rate of mortality that consists of elevation in pressure of the vessels through which blood flows to the lung. Sildenafil is a therapeutic option for the treatment of PAH in children for the fact that it relaxes the blood vessels and thereby improves pulmonary blood flow. The aim was to analyze the clinical behavior of an extemporaneous formulation of sildenafil as a therapeutic option in children with PAH, twelve children with PAH were studied. The ages and weights of the children ranged from 5 to 15 years and from 13 to 27 kg. All patients received a capsule of 1 mg/kg of sildenafil prepared as extemporaneous formulation in the pharmacology laboratory. Blood levels of sildenafil were analyzed in order to evaluate its availability of developed formulation. Management has derived from physiopathological knowledge and clinical presentations of patients. The mean maximum concentration was 550 ng/ml which is greater than levels reported in adults. Moreover, a therapeutic monitoring of sildenafil was carried out in order to establish an adequate therapeutic range for children and to show that dosages prepared extemporaneously meet the therapeutic needs for the management of PAH. With an average follow-up of once every 2 months, it was found that the evolution of the patients was favorable and without adverse effects that could put their life at risk. The management of PAH with sildenafil prepared as extemporaneous formulation might be considered as a good therapeutic option.


Sujet(s)
Préparation de médicament/méthodes , Hypertension pulmonaire/traitement médicamenteux , Citrate de sildénafil/administration et posologie , Citrate de sildénafil/usage thérapeutique , Administration par voie orale , Adolescent , Enfant , Enfant d'âge préscolaire , Relation dose-effet des médicaments , Femelle , Études de suivi , Humains , Hypertension pulmonaire/sang , Hypertension pulmonaire/physiopathologie , Mâle , Citrate de sildénafil/effets indésirables , Citrate de sildénafil/sang , Facteurs temps , Résultat thérapeutique , Vasodilatateurs/administration et posologie , Vasodilatateurs/usage thérapeutique
16.
Naunyn Schmiedebergs Arch Pharmacol ; 384(6): 499-504, 2011 Dec.
Article de Anglais | MEDLINE | ID: mdl-21826449

RÉSUMÉ

Malnutrition contributes to the development of oxidative damage in the central nervous system. The selective administration of nutrients tends to show positive results in individuals who have suffered from malnutrition. To determine the effect of the administration of cocoa powder on the peroxidation of lipids and glutathione level during the nutritional recovery in brain, rats of 21 days old were subjected to a protocol that resembles malnutrition (MN) by feeding them with 60% of the daily food consumption of the control group (WN) and later to nutritional recovery with regular rodent feed (RFR) or added with cocoa (10 g of cocoa powder/kg of regular rodent feed) (CCR). Animals fed with regular rodent food showed significant reduction in brain glutathione: RFR (84.18 ± 6.38 ng/mg protein) vs. CCR (210.61 ± 50.10 ng/mg protein) and WN (186.55 ± 33.18 ng/mg protein), but with similar level to that of MN (92.12 ± 15.60 ng/mg protein). On the contrary, lipid peroxidation in RFR-fed animals increased RFR (1.32 ± 0.2 µM malondialdehyde/g of tissue), CCR (0.86 ± 0.07 µM malondialdehyde/g of tissue), WN (0.89 ± 0.09 µM malondialdehyde/g of tissue), but their thiobarbituric acid reactive substances concentration is similar to that of MN group (1.50 ± 0.2 µM malondialdehyde/g of tissue). Consumption of cocoa powder as a source of antioxidants favors the restoration of the concentration of glutathione and reduces the damage caused by oxidative stress during nutritional recovery in rat brain.


Sujet(s)
Encéphale/effets des médicaments et des substances chimiques , Cacaoyer/composition chimique , Malnutrition/thérapie , Stress oxydatif/effets des médicaments et des substances chimiques , Animaux , Antioxydants/usage thérapeutique , Encéphale/anatomopathologie , Compléments alimentaires , Modèles animaux de maladie humaine , Aliments , Glutathion/effets des médicaments et des substances chimiques , Glutathion/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Mâle , Malnutrition/complications , Rats , Rat Wistar
17.
Proc West Pharmacol Soc ; 53: 20-5, 2010.
Article de Anglais | MEDLINE | ID: mdl-22128445

RÉSUMÉ

We analyzed the effect of marijuana and nalbuphine on levels of 5-hydroxyindol acetic acid and lipid peroxidation in rat brain. Single and repeated dosages of 250 mg/kg marijuana extract or 10 mg/kg nalbuphine were administered to male and female Wistar rats. Animals were sacrificed and brains were obtained to measure the content of 5-hydroxyindol acetic acid, reduced glutathione, thiobarbituric acid reactive substances, total ATPase and Na+/K+ ATPase activities. There was an increase in thiobarbituric acid reactive substances, total ATPase and Na+/K+ ATPase activity in the animals that received a single dose of marijuana and nalbuphine (p=0.001), with a notable decrease in glutathione and 5-hydroxyindol acetic acid levels (p=0.001). Both marijuana and nalbuphine increased levels of oxidative damage biomarkers in rat brain and decreased glutathione and 5-hydroxyindol acetic acid levels which could provoke changes in cellular and biochemical regulations and serotonergic activity in either male or female rats.


Sujet(s)
Encéphale/effets des médicaments et des substances chimiques , Cannabis , Acide 5-hydroxy-indole-3-acétique/analyse , Peroxydation lipidique/effets des médicaments et des substances chimiques , Adenosine triphosphatases/métabolisme , Animaux , Encéphale/métabolisme , Femelle , Glutathion/analyse , Mâle , Nalbuphine/pharmacologie , Rats , Rat Wistar
18.
Hum Exp Toxicol ; 28(9): 577-82, 2009 Sep.
Article de Anglais | MEDLINE | ID: mdl-19744972

RÉSUMÉ

The objective of the study is to determine the damage by oxidative stress induced by morphine in brain of rats fed with a protein-deficient diet. Twenty-eight malnourished male Wistar rats, 30 days old, were used in the study. The animals were divided into four groups of 7 rats per group. Group I received NaCl and the groups II; III and IV intraperitoneally received 3, 6 and 12 mg/kg of morphine sulphate, respectively, in a single dose. Animals were sacrificed and the levels of glutathione (GSH), dopamine, tryptophan and 5-hydroxyindole-3-acetic acid (5-HIAA) as well as, Na(+)/K(+) ATPase and total ATPase activity in the brain were measured. Tryptophan levels and Na(+)/K( +) ATPase activity showed non-significant changes in the experimental group. Levels of 5-HIAA decreased significantly (p = .03) in animals that received 12 mg/kg of morphine and in animals that received 3 mg/kg, levels of GSH and dopamine were found to have a significant decrease (p < .05), but a significant increase in the group that received 12 mg/kg of morphine (p < .05). Total ATPase activity increased significantly in the groups that received 3 mg/kg (p = .015) and 6 mg/kg (p = .0001) of morphine. The results show that malnutrition induces changes in cellular regulation and biochemical responses to oxidative stress caused by morphine sulphate.


Sujet(s)
Analgésiques morphiniques/effets indésirables , Encéphale/effets des médicaments et des substances chimiques , Morphine/effets indésirables , Stress oxydatif/effets des médicaments et des substances chimiques , Carence protéique/métabolisme , Animaux , Antioxydants/métabolisme , Marqueurs biologiques/métabolisme , Encéphale/enzymologie , Encéphale/métabolisme , Relation dose-effet des médicaments , Mâle , Rats , Rat Wistar
19.
Proc West Pharmacol Soc ; 52: 26-9, 2009.
Article de Anglais | MEDLINE | ID: mdl-22128415

RÉSUMÉ

We have compared the frequency and types of cancer chemotherapies used in a private hospital and in a government-based hospital in Mexico City. A retrospective study was conducted from January 2005 to December 2007, and therapeutic management determined in 415 cases reviewed by the attending physicians of the oncology service. In the government-based hospital, 60 different types of cancer were found among 273 patients diagnosed. Acute lymphoblastic leukemia (ALL) had the greatest incidence (30%), followed by Hodgkin's lymphoma (9%), retinoblastoma (7%), neuroblastoma (6%), and osteosarcoma (6%). The entire number of chemotherapy sessions was 7575. Drugs most frequently employed included etoposide (577), followed by methotrexate (575), vincristine (483), cyclophosphamide (312), and cytarabine (277). The economic status among these patients was mainly of limited resources and represented 80% of the total number of patients. The types of cancer found in the private hospital were similar, however the drugs used were predominantly cyclophosphamide (416), doxorubicin (382), 5-fluorouracil (368), paclitaxel (237) and cisplatin (128). The types of cancer were similar in both hospitals and reflected the incidence among the entire population in Mexico, since acute lymphoblastic leukemia, Hodgkin's lymphoma and retinoblastoma, were the types most represented. However, the treatment schemes differed; the chemotherapeutic agents used in the private hospital were rather more specific but significantly more expensive than those employed in the government hospital.


Sujet(s)
Tumeurs/traitement médicamenteux , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Nourrisson , Mâle , Mexique , Études rétrospectives
20.
Proc West Pharmacol Soc ; 51: 27-9, 2008.
Article de Anglais | MEDLINE | ID: mdl-19544669

RÉSUMÉ

Mexico City is among the world's largest metropolitan city centers and one of the most difficult and challenging cities in which to drive a motor vehicle. During peak transit hours and maximum congestion, numerous accidents occur, many of them fatal. The aim of the study presented here was to analyze the levels of select indicators against oxidative stress and levels of biogenic amines as a consequence of accident or altercation and fear deaths. Eighteen cases were studied (sixteen males, two females). Subjects ranged from twelve to eighty-one years of age. Nine of the deaths studied were the result of motor vehicle or subway accidents. Eight of the eighteen deaths were the result of a violent altercation, while one of the deaths resulted from a drug overdose and cardiac arrest. Biopsies of cadaver putamen were homogenized and analyzed for Tryptophan (Trp), 5-hydroxyindole acetic acid (5-HIAA), Dopamine (DA), and Glutathione (GSH) levels by fluorometric methods. Trp, 5-HIAA, DA, and GSH levels showed an increase in the subjects who's death was caused by violent altercation combined with fear, while DA levels showed significant differences in all accident groups. This data suggest that biogenic amines in cadaver putamen tissue, such as DA, can be telling biochemical markers, indicative of altercation and fear deaths.


Sujet(s)
Amines biogènes/métabolisme , Glutathion/métabolisme , Putamen/métabolisme , Plaies et blessures/métabolisme , Accidents , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Autopsie , Marqueurs biologiques/analyse , Enfant , Peur , Femelle , Humains , Mâle , Adulte d'âge moyen , Violence
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE